The Eye Center
Riyadh, Saudi Arabia
NCT Number: NCT01905579
The purpose of this study is to compare flaremetry readings with the protein content of the aqueous humor and the clinical grading of flare.
Looking for future studies?
Notify Me10 year–80 year
All sexes
Interventional
Not applicable
Riyadh, Saudi Arabia
A total of 20 patients will be included. 10 patients with uveitis and 10 control patients scheduled for phacoemulsification. Each patient will undego complete ophthalmic examination and clinical biomicroscopic grading of the anterior chamber flare applying the SUN working group grading system. Aqueous specimens will be obtained by anterior chamber paracentesis for protein analysis. Each Patient will undego paracentesis and 0.2 ml of aqueous will be obtained. The aqueous sample will be stored at -70°C until the time of analysis for protein content. Objective assessment of flare will be done.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Aqueous humor parenthesis for quantitative protein analysis in patients with and without uveitis.
Time frame: one month
Compare flaremetry readings with the protein content of the aqueous and the clinical grading.
The Eye Center and The Eye Foundation for Research in Ophthalmology
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01859299
Eye Diseases, Uveal Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05286203
Communicable Diseases, Disease Attributes
San Francisco, California, United States
View Trial DetailsNCT02656381
Behcet Syndrome, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04340505
Eye Diseases, Uveal Diseases
Cleveland, Ohio, United States
View Trial Details